Product
LY3954068
1 clinical trial
1 indication
Indication
Alzheimer's diseaseClinical trial
An Open-label, First-in-human, Multi-center Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of a Thorium-227 Labeled Antibody-chelator Conjugate, BAY2287411 Injection, in Patients With Solid Tumors Known to Express MesothelinStatus: Completed, Estimated PCD: 2021-09-29